Secondary placing of 5 million shares in Micronic Laser Systems (SE) — SEK 403 million TMT Secondary placing of 5 million shares in Micronic Laser Systems (SE) — SEK 403 million
New share issue in Biotage AB (SE) — SEK 97 million Healthcare New share issue in Biotage AB (SE) — SEK 97 million
Secondary placing of 9.1 million shares in Intrum Justitia (SE) — SEK 562 million TMT Secondary placing of 9.1 million shares in Intrum Justitia (SE) — SEK 562 million
Divestment of Bredbandsbolaget (SE) by Access Industries (US), The Carlyle Group (UK) and Investor (SE) to Telenor (NO) — SEK 6 billion TMT Divestment of Bredbandsbolaget (SE) by Access Industries (US), The Carlyle Group (UK) and Investor (SE) to Telenor (NO) — SEK 6 billion
Secondary placing of 3.5 million shares in Intrum Justitia (SE) — SEK 184 million FIG Secondary placing of 3.5 million shares in Intrum Justitia (SE) — SEK 184 million
New share issue in Biotage AB (SE) — SEK 34 million Healthcare New share issue in Biotage AB (SE) — SEK 34 million
Redemption offer in JM (SE) — SEK 966 million Real Estate Redemption offer in JM (SE) — SEK 966 million
Secondary placing of 3.4 million shares in MTV Production (SE) — SEK 100 million TMT Secondary placing of 3.4 million shares in MTV Production (SE) — SEK 100 million
Secondary placing of 965,000 shares in Meda AB (SE) — SEK 300 million Healthcare Secondary placing of 965,000 shares in Meda AB (SE) — SEK 300 million
Divestment of Svensk Etanolkemi AB, Sekab (SE) by Akzo Nobel and Domsjö Fabriker (SE) — Amount not disclosed. Industrials Divestment of Svensk Etanolkemi AB, Sekab (SE) by Akzo Nobel and Domsjö Fabriker (SE) — Amount not disclosed.
Repurchase programme in LjungbergGruppen (SE) — SEK 154 million Real Estate Repurchase programme in LjungbergGruppen (SE) — SEK 154 million
Divestment of Entific Medical Systems (SE) to Cochlear (AU) by CapMan, Investor Growth Capital and Nobel Biocare (SE) — SEK 1,050 million Healthcare Divestment of Entific Medical Systems (SE) to Cochlear (AU) by CapMan, Investor Growth Capital and Nobel Biocare (SE) — SEK 1,050 million